| Followers | 35 |
| Posts | 2238 |
| Boards Moderated | 0 |
| Alias Born | 10/18/2019 |
Friday, May 20, 2022 11:57:00 AM
If indeed it is found AF threatened Dr Liau that is totally inexcusable and legal action and punishment should take place.
The piece by AF saying the trial failed is imo less clear as it did fail on PFS and at the time the published protocol on clinicaltrials.gov for evaluating the trial had PFS as the primary endpoint. Yes from what we know the trial was a success but first chart at presentation showed pfs fail and government website showed that as the evaluation protocol so of course AF took full advantage. Could anyone expect anything different? That is imo 100% the fault of management as the updated evaluation protocol on clinicaltrials.gov should have been updated in 2020. Would seem imo this management can't anticipate anything no matter how obvious - this is AF's job and he is good at slamming companies. I have been through this many times before, sometimes quite profitably purchasing stock in companies he trashes
The piece by AF saying the trial failed is imo less clear as it did fail on PFS and at the time the published protocol on clinicaltrials.gov for evaluating the trial had PFS as the primary endpoint. Yes from what we know the trial was a success but first chart at presentation showed pfs fail and government website showed that as the evaluation protocol so of course AF took full advantage. Could anyone expect anything different? That is imo 100% the fault of management as the updated evaluation protocol on clinicaltrials.gov should have been updated in 2020. Would seem imo this management can't anticipate anything no matter how obvious - this is AF's job and he is good at slamming companies. I have been through this many times before, sometimes quite profitably purchasing stock in companies he trashes
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
